OverviewSuggest Edit

AnaptysBio is a biotechnology company developing immunology therapeutic product candidates. It focuses on immune control mechanisms applicable to inflammation and immuno-oncology indications. The company offers ANB019, ANB030, and ANB032 antibody programs to address inflammatory disorders.
HQSan Diego, US

Latest Updates

Employees (est.) (Dec 2019)89(-8%)
Job Openings18
Share Price (Mar 2020)$14 (-3%)

AnaptysBio Office Locations

AnaptysBio has an office in San Diego
San Diego, US (HQ)
10421 Pacific Center Ct Suite 200
Show all (1)

AnaptysBio Financials and Metrics

AnaptysBio Revenue

Market capitalization (27-Mar-2020)


Closing stock price (27-Mar-2020)

AnaptysBio's current market capitalization is $381.7 m.
Show all financial metrics

AnaptysBio Online and Social Media Presence

Embed Graph

AnaptysBio News and Updates

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages AnaptysBio (ANAB) Investors Who Have Suffered Losses to Contact its Attorneys: Securities Fraud Class Action Filed

SAN FRANCISCO, March 26, 2020 /PRNewswire/ -- Hagens Berman urges investors in AnaptysBio, Inc. (NASDAQ: ANAB) who have suffered significant losses to submit their losses now. A securities class action has been filed, and certain investors may have valuable claims. Class Period: Oct. 10,...

AnaptysBio Frequently Asked Questions

  • When was AnaptysBio founded?

    AnaptysBio was founded in 2005.

  • How many employees does AnaptysBio have?

    AnaptysBio has 89 employees.

  • Who are AnaptysBio competitors?

    Competitors of AnaptysBio include Clovis Oncology, Northwest Biotherapeutics and Merrimack Pharmaceuticals.

  • Where is AnaptysBio headquarters?

    AnaptysBio headquarters is located at 10421 Pacific Center Ct Suite 200, San Diego.

  • Where are AnaptysBio offices?

    AnaptysBio has an office in San Diego.

  • How many offices does AnaptysBio have?

    AnaptysBio has 1 office.